2-methoxyestradiol Restrains Non-small Cell Lung Cancer Tumorigenesis Through Regulating Circ_0010235/miR-34a-5p/NFAT5 Axis

Overview

Journal Thorac Cancer

Specialties Oncology
Pulmonary Medicine

Date 2023 Jul 13

PMID 37439026

Authors

Yong Zhang

Yuanyuan Mi

Chunhui He

Affiliations

Soon will be listed here.

Abstract

Background: Non-small cell lung cancer (NSCLC) is one of the most prevalent and severe malignant tumors in the world and its molecular mechanism is still unclear. In recent years, increasing evidence indicates the significant roles of circRNAs in NSCLC. It has been determined that 2-methoxyestradiol (2-MeOE2) exerts antitumor roles in many cancers. However, the molecular mechanism of 2-MeOE2 in regulating the development of lung cancer needs further elucidation.

Methods: The expression levels of circ_0010235, microRNA-34a-5p (miR-34a-5p), and nuclear factor of activated T cells 5 (NFAT5) were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation, apoptosis and invasion were detected by cell counting kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU) assay, flow cytometry and transwell assays, respectively. The interaction between miR-34a-5p and circ_0010235 or NFAT5 was predicted by bioinformatic software and confirmed by dual-luciferase reporter assay.

Results: Our data showed 2-MeOE2 hindered cell proliferation, invasion and induced apoptosis in NSCLC, which could be reversed by upregulation of circ_0010235 and NFAT5 or miR-34a-5p knockdown. Circ_0010235 and NFAT5 expression levels were increased, and miR-34a-5p expression level was decreased in NSCLC tissues and cells. In addition, 2-MeOE2 treatment suppressed the expression of circ_0010235 and NFAT5 while promoted the expression of miR-34a-5p. Furthermore, circ_0010235 functioned as a molecular sponge of miR-34a-5p to regulate NFAT5 expression. Knockdown of circ_0010235 or 2-MeOE2 treatment constrained tumor growth in vivo, and circ_0010235 depletion enhanced the inhibitory effect of 2-MeOE2 on tumor growth in vivo.

Conclusion: These findings demonstrated that 2-MeOE2 retarded NSCLC progression by modulating the circ_0010235/miR-34a-5p/NFAT5 axis, thus providing a new perspective for 2-MeOE2 treatment in NSCLC.

Citing Articles

Role of circular RNAs in cancer therapy resistance.

Liu W, Niu J, Huo Y, Zhang L, Han L, Zhang N Mol Cancer. 2025; 24(1):55.

PMID: 39994791 PMC: 11854110. DOI: 10.1186/s12943-025-02254-5.

Role of PGC-1α in the proliferation and metastasis of malignant tumors.

Zhang T, Zhao S, Gu C J Mol Histol. 2025; 56(2):77.

PMID: 39881043 DOI: 10.1007/s10735-025-10360-3.

Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.

Zhang Y, Lun H, Zhu N, Yang N, Ding K, Chen B Front Oncol. 2025; 14():1485605.

PMID: 39850812 PMC: 11754200. DOI: 10.3389/fonc.2024.1485605.

Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model.

Uzdrowska K, Knap N, Konieczna L, Kamm A, Kuban-Jankowska A, Gieraltowska J Int J Nanomedicine. 2025; 20():933-950.

PMID: 39850060 PMC: 11756907. DOI: 10.2147/IJN.S498947.

Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy.

Prabhakaran R, Thamarai R, Sivasamy S, Dhandayuthapani S, Batra J, Kamaraj C Epigenetics Chromatin. 2024; 17(1):31.

PMID: 39415281 PMC: 11484394. DOI: 10.1186/s13072-024-00554-6.

References

Ma E, Wang Q, Li J, Zhang X, Guo Z, Yang X . LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1. Cancer Cell Int. 2020; 20:515. PMC: 7574442. DOI: 10.1186/s12935-020-01577-1. View

Jamal-Hanjani M, Wilson G, McGranahan N, Birkbak N, Watkins T, Veeriah S . Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 376(22):2109-2121. DOI: 10.1056/NEJMoa1616288. View

Ba M, Duan Y . Advance of 2-methoxyestradiol as a promising anticancer agent for cancer therapy. Future Med Chem. 2020; 12(4):273-275. DOI: 10.4155/fmc-2019-0258. View

Shang Q, Yang Z, Jia R, Ge S . The novel roles of circRNAs in human cancer. Mol Cancer. 2019; 18(1):6. PMC: 6325800. DOI: 10.1186/s12943-018-0934-6. View

Verduci L, Strano S, Yarden Y, Blandino G . The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019; 13(4):669-680. PMC: 6441890. DOI: 10.1002/1878-0261.12468. View

Hong S, Li Q, Yang Y, Jing D, Zhu F . Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis. Mol Biotechnol. 2021; 64(2):144-155. DOI: 10.1007/s12033-021-00402-y. View

Zhang Y, Mi Y, He C . 2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235/miR-34a-5p/NFAT5 axis. Thorac Cancer. 2023; 14(22):2105-2115. PMC: 10396792. DOI: 10.1111/1759-7714.14993. View

Zhang F, Cheng R, Li P, Lu C, Zhang G . Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis. Cancer Cell Int. 2021; 21(1):73. PMC: 7836483. DOI: 10.1186/s12935-021-01764-8. View

Hu X, Wang P, Qu C, Zhang H, Li L . Circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered. 2021; 12(1):6229-6239. PMC: 8806897. DOI: 10.1080/21655979.2021.1965697. View

10.

Zhang S, Liao K, Miao Z, Wang Q, Miao Y, Guo Z . CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Neuro Oncol. 2019; 21(10):1284-1296. PMC: 6784278. DOI: 10.1093/neuonc/noz128. View

11.

Li C, Zhang L, Meng G, Wang Q, Lv X, Zhang J . Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 2019; 145(12):2875-2889. DOI: 10.1007/s00432-019-03045-4. View

12.

Shaw J, Utz P, Durand D, Toole J, Emmel E, Crabtree G . Identification of a putative regulator of early T cell activation genes. Science. 1988; 241(4862):202-5. DOI: 10.1126/science.3260404. View

13.

Bade B, Dela Cruz C . Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020; 41(1):1-24. DOI: 10.1016/j.ccm.2019.10.001. View

14.

Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

15.

Zhu Y, Ma C, Lv A, Kou C . Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A. Ann Med. 2021; 53(1):693-706. PMC: 8158223. DOI: 10.1080/07853890.2021.1925736. View

16.

Li H, Duan Y, Zhao N . MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells. Eur Rev Med Pharmacol Sci. 2021; 25(3):1250-1260. DOI: 10.26355/eurrev_202102_24829. View

17.

Li S, Liu Y, Qiu G, Luo Y, Li X, Meng F . Emerging roles of circular RNAs in non‑small cell lung cancer (Review). Oncol Rep. 2021; 45(4). PMC: 7876988. DOI: 10.3892/or.2021.7968. View

18.

Fu S, Zhang Y, Li S, Shi Z, Zhao J, He Q . LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis. Cancer Cell Int. 2020; 20:415. PMC: 7453543. DOI: 10.1186/s12935-020-01378-6. View

19.

Geng Y, Wu Y, Xu C, Li T, Zhang L . Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma. Onco Targets Ther. 2020; 13:10161-10172. PMC: 7553658. DOI: 10.2147/OTT.S272616. View

20.

Zhao H, Jiang H, Li Z, Zhuang Y, Liu Y, Zhou S . 2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis. Int J Oncol. 2017; 50(5):1531-1540. PMC: 5403226. DOI: 10.3892/ijo.2017.3924. View